Survival in End-Stage HF Patients Ineligible for Cardiac Transplant can Exceed 10 Years With LVAD ‘Destination Therapy’
| Autor: | McLean, J., Baumwol, J., Shah, A., Silbert, B., Hayes, H., Della-Bosca, F. |
|---|---|
| Zdroj: | In Heart, Lung and Circulation August 2024 33 Supplement 4:S287-S287 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect